Healthcare -
Biotechnology - NASDAQ - US
$ 2.78
-0.714 %
$ 58.6 M
Market Cap
-0.63
P/E
Price Target
Average
--16.07%
Revenue Forecast
Estimate
279.24%
EBIT
Estimate
86.39%
Net Income
Estimate
62.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
OncoCyte Corporation
Wall Street analysts predict an average 1-year price target for OCX of $2.33 , with forecasts ranging from
a
low of
$0.5 to a high of $4.25 .
OCX Lowest Price Target
Wall Street Target
0.5 USD
-82.01%
OCX Average Price Target
Wall Street Target
2.33 USD
-16.07%
OCX Highest Price Target
Wall Street Target
4.25 USD
52.88%
REVENUE FORECAST
Revenue Forecast Chart OCX
EBIT FORECAST
EBIT Forecast Chart OCX
NET INCOME FORECAST
Net Income Chart OCX